Lukatch Heath's Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Jan 4, 2024
- Accession no.
- 0001209191-24-000783
- Filed
- Jan 4, 2024
- Trade date
- Jan 2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $828.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lukatch HeathCIK 0001596385 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseAcquired | +13,000 | $16.00 | +$208,000 | 18,625 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −1,101 | $62.85 | −$69,197.85 | 17,524 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −7,444 | $63.55 | −$473,066.2 | 10,080 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −4,164 | $64.28 | −$267,661.92 | 5,916 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −291 | $65.19 | −$18,970.29 | 5,625 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseDisposed | −13,000 | $0.00 | $0 | 15,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.